15 July 2022
DBL Pharmaceuticals Limited has successfully arranged the first ever Advisory Board Meeting on behalf of their Cardiovascular portfolio on 15 July 2022 at Hotel Intercontinental, Dhaka.
At the beginning of the program honorable Executive Director, Business Operations Mr. Ahmed Kamrul Alam gave a welcome note to the participants of the program, and Mr. Md. Shahriar Hasan Khondoker (Manager, Marketing) presented a short presentation on the differentiation of DBL Pharma.
The main discussion topic was presented by legendary Cardiologist Prof. (Dr.) Abdullah Al Shafi Majumder (Former Director, National Institute of Cardiovascular Disease & Secretary General, Bangladesh Cardiac Society). After the presentation, an open discussion took place by the panel of renowned Cardiologists & Medicine Specialists of Bangladesh.
The other Advisory board members were:
DBL Pharmaceuticals Ltd. recently held its 1st Annual Business Conference at Hotel Sea Palace, Cox’s Bazar on 5th January 2023. DBL Pharma marked this conference to align its field force with a crafted vision of serving humanity by providing high-quality and differentiated medicines. Deputy Managing Director & Group CEO Mr. M. A. Quader inaugurated the… Continue reading DBL Pharma holds its 1st Annual Business Conference
DBL Pharma celebrates World Heart Day 2022
Cardiovascular disease is a growing burden and one of the leading causes of death in Bangladesh. In most cases, the exact cause of CVD is not known, but a combination of factors can increase the risk of getting heart disease. Considering the risk factors associated with heart disease, DBL Pharma has celebrated “World Heart Day… Continue reading DBL Pharma celebrates World Heart Day 2022